- Preview Available
- Scholarly Journal
Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies
NPJ Parkinson's Disease; London Vol. 11, Iss. 1, (2025): 132.
DOI:10.1038/s41531-024-00849-1
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.